Mapping COVID-19 related research from Saudi Arabia, a scoping review

References

1. ↵
   1. World Health Organization

   Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV), Available from URL:https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). [Updated 2020 January 30. Cited 2020 February 18].
2. ↵
   1. World Health Organization

   WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020, Available from URL:https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Updated 2020 March 11. Cited 2020 March 20.
3. ↵
   Worldmeter COVID-19 Coronavirus pandemic, Available from URL:https://www.worldometers.info/coronavirus/. [Updated 2020 June 18. Cited 2020].
4. ↵
   Twitter. The Saudi Ministry of Health (MOH), Available from URL:https://twitter.com/SaudiMOH/status/1258014834890809345. [Updated 2020 May 6. Accessed 2020 May 6].
5. ↵
   1. Huang C,
   2. Wang Y,
   3. Li X,
   4. Ren L,
   5. Zhao J,
   6. Hu Y,
   7. et al.

   (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506.

   OpenUrlCrossRefPubMed
6. 1. Wang D,
   2. Hu B,
   3. Hu C,
   4. Zhu F,
   5. Liu X,
   6. Zhang J,
   7. et al.

   (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061–1069.

   OpenUrlCrossRefPubMed
7. ↵
   1. He F,
   2. Deng Y,
   3. Li W

   (2020) Coronavirus Disease 2019 (COVID-19):what we know? J Med Virol 92:719–725.

   OpenUrlPubMed
8. ↵
   1. Zhou P,
   2. Yang XL,
   3. Wang XG,
   4. Hu B,
   5. Zhang L,
   6. Zhang W,
   7. et al.

   (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273.

   OpenUrlCrossRefPubMed
9. ↵
   1. Center for Disease Control and Prevention

   Coronavirus (2019-nCoV) situation summary, Available from URLhttps://www.cdc.gov/coronavirus/2019-ncov/summary.html. [Updated 2020 February 11. Cited 2020 April 22].
10. ↵
    1. Li Q,
    2. Guan X,
    3. Wu P,
    4. Wang X,
    5. Zhou L,
    6. Tong Y,
    7. et al.

    (2020) Early transmission dynamics in Wuhan, China, of Novel Coronavirus-infected pneumonia. N Engl J Med 382:1199–1207.

    OpenUrlCrossRefPubMed
11. ↵
    WHO, Modes of transmission of virus causing COVID-19 implications for IPC precaution recommendations Scientific brief. Available from URL:https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations. [Updated 2020 March 29. Cited 2020 April 22.].
12. ↵
    1. Chan JF,
    2. Yuan S,
    3. Kok KH,
    4. To KK,
    5. Chu H,
    6. Yang J,
    7. et al.

    (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission:a study of a family cluster. Lancet 395:514–523.

    OpenUrlCrossRefPubMed
13. ↵
    1. World Health Organization

    Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Updated 2020 February. Accessed 2020 May 6.
14. ↵
    1. Zhao S,
    2. Lin Q,
    3. Ran J,
    4. Musa SS,
    5. Yang G,
    6. Wang W,
    7. et al.

    (2020) Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020:a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 92:214–217.

    OpenUrlCrossRefPubMed
15. ↵
    1. Chen N,
    2. Zhou M,
    3. Dong X,
    4. Qu J,
    5. Gong F,
    6. Han Y,
    7. et al.

    (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:a descriptive study. Lancet 395:507–513.

    OpenUrlCrossRefPubMed
16. ↵
    1. Haleem A,
    2. Javaid M,
    3. Vaishya R,
    4. Deshmukh SG

    (2020) Areas of academic research with the impact of COVID-19. Am J Emerg Med 20:30250–30253.

    OpenUrl
17. ↵
    1. Arksey H,
    2. O'Malley L

    (2005) Scoping studies:Towards a methodological framework. Int J Soc Res Methodol 8:19–32.

    OpenUrlCrossRef
18. ↵
    1. Tricco AC,
    2. Lillie E,
    3. Zarin W,
    4. O'Brien K,
    5. Colquhoun H,
    6. Kastner M,
    7. et al.

    (2016) A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol 16:15.

    OpenUrlPubMed
19. ↵
    1. Elfiky AA

    (2020) Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci 248:117477.

    OpenUrl
20. ↵
    1. Ducournau F,
    2. Arianni M,
    3. Awwad S,
    4. Baur EM,
    5. Beaulieu JY,
    6. Bouloudhnine M,
    7. et al.

    (2020) COVID-19:Initial experience of an international group of hand surgeons. Hand Surg Rehabil 39:159–166.

    OpenUrlPubMed
21. ↵
    1. Angus DC,
    2. Berry S,
    3. Lewis RJ,
    4. Al-Beidh F,
    5. Arabi Y,
    6. van Bentum-Puijk W,
    7. et al.

    (2020) The Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) Study:Rationale and Design. Ann Am Thorac Soc, 1–373.
22. 1. Alhazzani W,
    2. Møller M,
    3. Arabi Y,
    4. Loeb M,
    5. Gong M,
    6. Fan E,
    7. et al.

    (2020) Surviving Sepsis Campaign:guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 134.
23. 1. Al-Tawfiq JA

    (2020) Asymptomatic coronavirus infection:MERS-CoV and SARS-CoV-2 (COVID-19). Travel Med Infect Dis, 101608.
24. 1. Al-Qaness MAA,
    2. Ewees AA,
    3. Fan H,
    4. Abd El,
    5. Aziz M

    (2020) Optimization method for forecasting confirmed cases of COVID-19 in China. J Clin Med 9:674.

    OpenUrl
25. 1. Xu J,
    2. Zhao S,
    3. Teng T,
    4. Abdalla AE,
    5. Zhu W,
    6. Xie L,
    7. et al.

    (2020) Systematic comparison of two animal-to-human transmitted human coronaviruses:SARS-CoV-2 and SARS-CoV. Viruses 12:244.

    OpenUrlCrossRef
26. 1. Bedford J,
    2. Enria D,
    3. Giesecke J,
    4. Heymann DL,
    5. Ihekweazu C,
    6. Kobinger G,
    7. et al.

    (2020) COVID-19:towards controlling of a pandemic. Lancet 395:1015–1018.

    OpenUrlCrossRefPubMed
27. 1. Arabi YM,
    2. Murthy S,
    3. Webb S

    (2020) COVID-19:a novel coronavirus and a novel challenge for critical care. Intensive Care Med 40:833–836.

    OpenUrl
28. 1. Nasir MU,
    2. Roberts J,
    3. Muller NL,
    4. Macri F,
    5. Mohammed MF,
    6. Akhlaghpoor S,
    7. et al.

    (2020) The role of emergency radiology in COVID-19:from preparedness to diagnosis. Can Assoc Radiol J, 846537120916419.
29. 1. Sah R,
    2. Rodriguez-Morales AJ,
    3. Jha R,
    4. Chu DKW,
    5. Gu H,
    6. Peiris M,
    7. et al.

    (2020) Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal. Microbiol Resour Announc 9:e00169–e00120.

    OpenUrlCrossRefPubMed
30. ↵
    1. Gautret P,
    2. Al-Tawfiq JA,
    3. Hoang VT

    (2020) COVID 19:Will the 2020 Hajj pilgrimage and Tokyo Olympic Games be cancelled? Travel Med Infect Dis 34:101622.

    OpenUrl
31. 1. Rodriguez-Morales AJ,
    2. Bonilla-Aldana DK,
    3. Balbin-Ramon GJ,
    4. Rabaan AA,
    5. Sah R,
    6. Paniz-Mondolfi A,
    7. et al.

    (2020) History is repeating itself:probable zoonotic spillover as the cause of the 2019 Novel Coronavirus Epidemic. Infez Med 28:3–5.

    OpenUrl
32. 1. Arab-Mazar Z,
    2. Sah R,
    3. Rabaan AA,
    4. Dhama K,
    5. Rodriguez-Morales AJ

    (2020) Mapping the incidence of the COVID-19 hotspot in Iran - implications for travellers. Travel Med Infect Dis 34:101630.

    OpenUrlCrossRef
33. 1. Kandeel M,
    2. Ibrahim A,
    3. Fayez M,
    4. Al-Nazawi M

    (2020) From SARS and MERS CoVs to SARS-CoV-2:Moving toward more biased codon usage in viral structural and nonstructural genes. J Med Virol 92:660–666.

    OpenUrl
34. 1. Meo SA,
    2. Alhowikan AM,
    3. Al-Khlaiwi T,
    4. Meo IM,
    5. Halepoto DM,
    6. Iqbal M,
    7. et al.

    (2020) Novel coronavirus 2019-nCoV:prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci 24:2012–2019.

    OpenUrlCrossRefPubMed
35. 1. Farooq I,
    2. Ali S

    (2020) COVID-19 outbreak and its monetary implications for dental practices, hospitals and healthcare workers. Postgrad Med J 137781.
36. 1. Al-Tawfiq JA

    (2020) Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and COVID-19 infection during pregnancy. Travel Med Infect Dis, 101641.
37. 1. Khurshid Z,
    2. Asiri FYI,
    3. Al Wadaani H

    (2020) Human saliva:non-invasive fluid for detecting Novel Coronavirus (2019-nCoV). Int J Environ Res Public Health 17:2225.

    OpenUrlCrossRefPubMed
38. 1. Arabi YM,
    2. Fowler R,
    3. Hayden FG

    (2020) Critical care management of adults with community-acquired severe respiratory viral infection. Intensive Care Med 46:315–328.

    OpenUrl
39. 1. Ibrahim IM,
    2. Abdelmalek DH,
    3. Elshahat ME,
    4. Elfiky AA

    (2020) COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect 80:554–562.

    OpenUrlCrossRef
40. 1. Rodriguez-Morales AJ,
    2. Cardona-Ospina JA,
    3. Gutiérrez-Ocampo E,
    4. Villamizar-Peña R,
    5. Holguin-Rivera Y,
    6. Escalera-Antezana JP,
    7. et al.

    (2020) Clinical, laboratory and imaging features of COVID-19:A systematic review and meta-analysis. Latin American Network of Coronavirus Disease 2019-COVID-19 research (LANCOVID-19). Travel Med Infect Dis 34:101623.

    OpenUrlCrossRefPubMed
41. 1. Al Nsour M,
    2. Bashier H,
    3. Al Serouri A,
    4. Malik E,
    5. Khader Y,
    6. Saeed K,
    7. et al.

    (2020) The role of the Global Health Development/Eastern Mediterranean Public Health Network and the Eastern Mediterranean Field Epidemiology Training Programs in preparedness for COVID-19. JMIR Public Health Surveill 6:e18503.

    OpenUrl
42. 1. Ralph R,
    2. Lew J,
    3. Zeng T,
    4. Francis M,
    5. Xue B,
    6. Roux M,
    7. et al.

    (2020) 2019-nCoV (Wuhan virus), a novel Coronavirus:human-to-human transmission, travel-related cases, and vaccine readiness. J Infect Dev Ctries 14:3–17.

    OpenUrlCrossRef
43. 1. Al-Tawfiq JA

    (2020) Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens:What have we learned? Travel Med Infect Dis 101629.
44. 1. Ebrahim SH,
    2. Ahmed QA,
    3. Gozzer E,
    4. Schlagenhauf P,
    5. Memish ZA

    (2020) Covid-19 and community mitigation strategies in a pandemic. BMJ 368:m1066.

    OpenUrlFREE Full Text
45. 1. Ahmed QA,
    2. Memish ZA

    (2020) The cancellation of mass gatherings (MGs)?Decision making in the time of COVID-19. Travel Med Infect Dis 34:101631.

    OpenUrlCrossRefPubMed
46. 1. Barry M,
    2. Al Amri M,
    3. Memish ZA

    (2020) COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia. J Epidemiol Glob Health 10:1–3.

    OpenUrl
47. 1. Ebrahim SH,
    2. Memish ZA

    (2020) COVID-19 –the role of mass gatherings. Travel Med Infect Dis 34:101617.

    OpenUrl
48. 1. Al-Tawfiq JA,
    2. Memish ZA

    (2020) Diagnosis of SARS-CoV-2 infection based on CT scan vs. RT-PCR:reflecting on experience from MERS-CoV. J Hosp Infect 105:154–155.

    OpenUrl
49. 1. Al-Tawfiq JA,
    2. Al-Homoud AH,
    3. Memish ZA

    (2020) Remdesivir as a possible therapeutic option for the COVID-19. Travel Med Infect Dis 34:101615.

    OpenUrl
50. 1. Petersen E,
    2. Hui D,
    3. Hamer DH,
    4. Blumberg L,
    5. Madoff LC,
    6. Pollack M,
    7. et al.

    (2020) Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak. Int J Infect Dis 93:205–207.

    OpenUrlCrossRefPubMed
51. 1. Ebrahim SH,
    2. Memish ZA

    (2020) COVID-19:preparing for superspreader potential among Umrah pilgrims to Saudi Arabia. Lancet 395:e48.

    OpenUrlCrossRefPubMed
52. 1. Ebrahim SH,
    2. Memish ZA

    (2020) Saudi Arabia`s measures to curb the COVID-19 outbreak:temporary suspension of the Umrah pilgrimage. J Travel Med, pii:taaa029.
53. 1. Zumla A,
    2. Hui DS,
    3. Azhar EI,
    4. Memish ZA,
    5. Maeurer M

    (2020) Reducing mortality from 2019-nCoV:host-directed therapies should be an option. Lancet 395:e35–e36.

    OpenUrlPubMed
54. 1. Hui DS,
    2. I Azhar E,
    3. Madani TA,
    4. Ntoumi F,
    5. Kock R,
    6. Dar O,
    7. et al.

    (2020) The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 91:264–266.

    OpenUrlCrossRefPubMed
55. 1. Hemida MG,
    2. Ba Abduallah MM

    (2020) The SARS-CoV- 2 outbreak from a one health perspective. One Health, 100127.
56. 1. Islam A,
    2. Ahmed A,
    3. Naqvi IH,
    4. Parveen S

    Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020. Virusdisease 2020:1–9.
57. 1. Meo SA,
    2. Al-Khlaiwi T,
    3. Usmani AM,
    4. Meo AS,
    5. Klonoff DC,
    6. Hoang TD

    (2020) Biological and epidemiological trends in the prevalence and mortality due to outbreaks of Novel Coronavirus COVID-19. J King Saud Univ Sci.
58. 1. Alharbi A,
    2. Alharbi S,
    3. Alqaidi S

    (2020) Guidelines for dental care provision during the COVID-19 pandemic. Saudi Dent J 32:181–186.

    OpenUrl
59. 1. Al-Tawfiq JA,
    2. Rodriguez-Morales AJ

    (2020) Super-spreading events and contribution to transmission of MERS, SARS, and COVID-19. J Hosp Infect 105:111–112.

    OpenUrl
60. 1. Rabaan AA,
    2. Al-Ahmed SH,
    3. Haque S,
    4. Sah R,
    5. Tiwari R,
    6. Malik YS,
    7. et al.

    (2020) SARS-CoV-2, SARS-CoV, and MERS-COV:A comparative overview. Infez Med 28:174–184.

    OpenUrlPubMed
61. 1. Rodriguez-Morales AJ,
    2. Balbin-Ramon GJ,
    3. Rabaan AA,
    4. Sah R,
    5. Dhama K,
    6. Paniz-Mondolfi A,
    7. et al.

    (2020) Genomic epidemiology and its importance in the study of the COVID-19 pandemic. Infez Med 28:139–142.

    OpenUrl
62. 1. Hasan A,
    2. Paray BA,
    3. Hussain A,
    4. Qadir FA,
    5. Attar F,
    6. Aziz FM,
    7. et al.

    A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J Biomol Struct Dyn 2020:1–9.
63. 1. Phua J,
    2. Weng L,
    3. Ling L,
    4. Egi M,
    5. Lim CM,
    6. Divatia JV,
    7. et al.

    (2020) Intensive care management of coronavirus disease 2019 (COVID-19):challenges and recommendations. Lancet Respir Med 8:506–517.

    OpenUrl
64. 1. Al-Tawfiq JA,
    2. Memish ZA

    (2020) COVID-19 in the Eastern Mediterranean Region and Saudi Arabia:prevention and therapeutic strategies. Int J Antimicrob Agents 55:105968.

    OpenUrlPubMed
65. 1. Kandeel M,
    2. Al-Nazawi M

    (2020) Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sci 251:117627.

    OpenUrl
66. 1. Mallineni SK,
    2. Innes NP,
    3. Raggio DP,
    4. Araujo MP,
    5. Robertson MD,
    6. Jayaraman J

    (2020) Coronavirus disease (COVID?19):characteristics in children and considerations for dentists providing their care. Int J Paediatr Dent 30:1–6.

    OpenUrl
67. 1. Memish ZA,
    2. Ahmed QA,
    3. Schlagenhauf P,
    4. Doumbia S,
    5. Khan A

    (2020) No time for dilemma:mass gatherings must be suspended. Lancet 395:1191–1192.

    OpenUrl
68. 1. Whiteside T,
    2. Kane E,
    3. Aljohani B,
    4. Alsamman M,
    5. Pourmand A

    (2020) Redesigning emergency department operations amidst a viral pandemic. Am J Emerg Med, S0735-6757(20)30262-X.
69. 1. Yezli S,
    2. Khan A

    (2020) COVID-19 social distancing in the Kingdom of Saudi Arabia:Bold measures in the face of political, economic, social and religious challenges. Travel Med Infect Dis, 101692.
70. 1. Atique S,
    2. Itumalla R

    (2020) Hajj in the Time of COVID-19. Infect Dis Health, S2468-0451(20)30023-7.
71. 1. Petersen E,
    2. McCloskey B,
    3. Hui D,
    4. Kock R,
    5. Ntoumi F,
    6. Memish Z

    (2020) COVID-19 travel restrictions and the International Health Regulations - call for an open debate on easing of travel restrictions. Int J Infect Dis 94:88–90.

    OpenUrl
72. ↵
    1. World Health Organization

    An R&D blueprint for action to prevent epidemics, Available form URL:https://www.who.int/who-documents-detail/an-r-d-blueprint-for-action-to-prevent-epidemics. Updated 2017. Cited 2020 April 28.
73. ↵
    1. Excler JL,
    2. Delvecchio CJ,
    3. Wiley RE,
    4. Williams M,
    5. Yoon IK,
    6. Modjarrad K,
    7. et al.

    (2016) Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015. Emerg Infect Dis 22:e1–e7.

    OpenUrl